BASF and leadXpro announce research collaboration
BASF and leadXpro AG will join forces to collaborate on the structure-based discovery of new active ingredients by employing single particle cryo-electron microscopy.
Latest developments, partnerships and scientific breakthroughs
BASF and leadXpro AG will join forces to collaborate on the structure-based discovery of new active ingredients by employing single particle cryo-electron microscopy.
leadXpro AG scientists explore the utility of cutting-edge X-ray technologies for the discovery of new therapeutics.
Creoptix and leadXpro AG announce the selection of the Creoptix WAVE technology by leadXpro to strengthen its capabilities for drug discovery aimed at identifying and optimizing drug candidates directed against challenging membrane protein drug targets.
leadXpro and AXXAM announce the collaboration for the discovery of small molecular ligands to a novel inflammation related GPCR target.
Tripling its physical footprint and with a new funding round secured, leadXpro AG is well-prepared for further development.
In collaboration with a major pharma company, leadXpro AG announced today the successful delivery of multiple GPCR structure determination milestones ahead of schedule.
leadXpro AG announced today a collaboration with Bayer AG to enable structure based drug discovery of membrane protein targets, facilitated by single particle cryo-Electron Microscopy (cryo-EM)
Park InnovAARE files building application for leadXpro’s future home
leadXpro proudly reports a collaboration contract with Boehringer Ingelheim